Clinical studies recruiting near Montgomery

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · NRG Oncology · NCT05174169 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · DCR Montgomery · Takeda · NCT06963827 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06876714 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · River Region Dermatology and Laser- Site Number : 8400041 · Sanofi · NCT07290803 Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Phase N/A · Home-based telemedicine · Ensoma · NCT06605378 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · NRG Oncology · NCT06748222 Clinical and Biochemical Effects of a Defined Plant-Based Diet on Heart Disease
NA · Georgia State University · NCT06994624 Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pM
Phase 2/Phase 3 · Renal Associates · Vertex Pharmaceuticals Incorporated · NCT07204275 A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite
Phase N/A · Bayer · NCT07330258 A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With
Phase 3 · Research Site · AstraZeneca · NCT06023589 A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Phase 2 · Research Site · Maze Therapeutics · NCT06830629 Manipulation and Dry Needling in Patients With Cervicogenic Headache and WAD II
NA · Alabama Physical Therapy & Acupuncture · Alabama Physical Therapy & Acupuncture · NCT06502951 Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation
NA · Five Horizons Health Services · University of Alabama at Birmingham · NCT07292584 MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Stryker Instruments · NCT03072927 A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in
Phase 3 · Merck Sharp & Dohme LLC · NCT06841354 A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
Phase 2 · Chambliss Clinical Trials, LLC · Novo Nordisk A/S · NCT07639021 Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
Phase 3 · Prokidney · NCT05099770 A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metasta
Phase 2 · Ohio State University Telemedicine · Sameek Roychowdhury · NCT06906562 Serranator POINT FORCE Registry
Phase N/A · Cagent Vascular LLC · NCT06687590 EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes,
Phase 3 · Boehringer Ingelheim · NCT07064473 Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal
Phase 3 · NRG Oncology · NCT05879926 Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Phase 2/Phase 3 · Renal Associates of Alabama, LLC · Vertex Pharmaceuticals Incorporated · NCT05312879 Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Phase 3 · Investigative Site US098 · Incyte Corporation · NCT06855498 Clinical Trial on Agitation in Alzheimer's Dementia
Phase 2 · IGC Pharma, LLC · NCT05543681 Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Phase N/A · Alliance for Clinical Trials in Oncology · NCT05334069 Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
Phase N/A · C2 Research Center · Pfizer · NCT06531109 Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (
Phase 2/Phase 3 · DaVita Clinical Research Montgomery · CSL Behring · NCT05485961 Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Scle
Phase 3 · Novartis Pharmaceuticals · NCT06846281

Look up another city

Look up another condition